https://www.selleckchem.com/products/gdc-0068.html
Patients only on insulin treatment and patients on both oral antidiabetic agents (OAD) and insulin had higher variability than patients only on OAD (P = 0.002; P less then 0.01). Patients with variability had higher HbA1c levels than patients without variability (P less then 0.01). A 1% increase in HbA1c had a 4.864-fold (95% confidence interval 2.360-10.023) increased variability risk. Conclusions HbA1c variability is seen in 9 of 10 patients with T2DM and higher HbA1c values and poor glycemic control are associated with a higher
Like
Comment
Share
